Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects
- PMID: 3346696
- PMCID: PMC1031546
- DOI: 10.1136/jnnp.51.2.285
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects
Abstract
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical